Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

This study has been completed.

Study NCT00023621 Information provided by National Cancer Institute (NCI)

First Received: September 13, 2001 Last Updated: July 23, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Non-Melanomatous Skin Cancer

Additional conditions recognized in this trial

Basal Cell Nevus Syndrome
Carcinoma, Basal Cell
Skin Neoplasms
Syndrome

Interventions listed in this trial

celecoxib

More general drug interventions related to this trial

Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses

Sponsors listed in this trial

UCSF Helen Diller Family Comprehensive Cancer Center
National Cancer Institute (NCI)

Back to top of Main Content